S-4879-119
Read twice and referred to the Committee on the Judiciary.
Sponsored by Patty Murray (D-WA)
What it does
This bill would prohibit any individual, entity, or state from preventing or restricting a licensed health care provider from offering reproductive health care services — including abortion, contraception, and in vitro fertilization — that are lawful in the state where they are provided. It would authorize the U.S. Attorney General and private parties to sue states or officials that violate this prohibition, and would explicitly abrogate state sovereign immunity for such suits. The bill would also appropriate $40 million for legal defense grants to providers facing litigation, $40 million for security grants to abortion providers, and would bar professional liability insurers from denying coverage to providers solely because they offer reproductive health care services.
Who benefits
Licensed health care providers (physicians, nurse practitioners, pharmacists, certified nurse-midwives, physician assistants) who offer abortion, contraception, IVF, or related services in states where those services are legal. Patients seeking those services, including out-of-state patients traveling to states where services are lawful. Legal organizations that would receive grant funding to defend providers. Abortion clinic staff who would benefit from security grants. Telehealth platforms offering reproductive health services. IVF clinics and fertility patients in states where IVF access has been legally uncertain.
Who is hurt
States that have enacted restrictions on reproductive health care providers would lose enforcement authority and face federal litigation exposure. State officials who implement such restrictions could be personally sued. Professional liability insurers would face new federal mandates on coverage decisions. Taxpayers would bear the cost of the $80 million in direct appropriations. States that receive federal funding could face conditions tied to compliance. Providers in states where certain services are unlawful would not benefit, as the bill's protections apply only to services lawful in the state where provided.
Supporters argue
Supporters argue that since Dobbs v. Jackson Women's Health Organization (2022) returned abortion regulation to states, a patchwork of state laws has created legal jeopardy for providers even when offering services that are fully lawful where performed — chilling care and driving providers out of practice. They contend the bill uses well-established Commerce Clause authority to protect interstate commerce in health care services, mirroring the structure upheld in NFIB v. Sebelius (2012), and that the legal defense and security grant programs address documented threats and litigation costs that have already reduced provider availability in multiple states.
Opponents argue
Opponents argue that Dobbs explicitly returned authority over abortion regulation to state legislatures, and that this bill attempts to use federal Commerce Clause power to override that democratic choice — raising the same concerns about federal overreach that animated NFIB v. Sebelius (2012). They further contend that the bill's abrogation of state sovereign immunity under the Tenth and Eleventh Amendments is constitutionally suspect, as Congress may only abrogate immunity through unambiguous invocation of Section 5 of the Fourteenth Amendment, and that the bill does not clearly rest on that authority — a gap courts may find fatal.
Constitutional context
The bill invokes the Commerce Clause (Art. I, §8, cl. 3) by defining covered services as those that "in any way affect commerce." Under NFIB v. Sebelius (2012), Congress may regulate existing commercial activity but cannot compel it; this bill regulates providers already engaged in commerce, which is a stronger footing. However, the bill's explicit abrogation of Eleventh Amendment immunity is constitutionally significant: Congress may abrogate state immunity only through a clear statement exercising Section 5 of the Fourteenth Amendment, and the bill's reliance on the Commerce Clause alone for that abrogation may not survive judicial review under Seminole Tribe v. Florida (1996) and its progeny.
Checks and balances
The executive branch (Attorney General and HHS Secretary) gains new enforcement and grant-making authority; Congress retains oversight through appropriations; federal courts serve as the primary check through judicial review of both the bill's constitutionality and individual enforcement actions.
Historical precedent
The Freedom of Access to Clinic Entrances Act (1994) similarly used Commerce Clause authority to create federal protections for reproductive health care providers and patients, establishing a private right of action and criminal penalties for obstruction of clinic access.